Bodal Chemicals adopts FY26 financials at 40th AGM
- Bodal Chemicals held its 40th AGM on September 25, 2026
- Shareholders adopted audited FY26 standalone and consolidated financials
- Ankit S Patel reappointed as director after retiring by rotation
- Cost auditor remuneration for FY27 ratified by members

*this image is generated using AI for illustrative purposes only.
Bodal Chemicals Ltd held its 40th Annual General Meeting on September 25, 2026, via video conferencing. Shareholders adopted the audited financial statements for FY26 and appointed Ankit S Patel as a director.
The meeting commenced at 12:07 pm and concluded at 12:26 pm. Suresh J Patel, Chairman and Managing Director, chaired the session. The notice convening the AGM and the annual report for the year ended March 31, 2026, were taken as read as they had been circulated to members previously.
Key resolutions passed
Shareholders transacted both ordinary and special business through remote e-voting and electronic voting during the meeting. The following items were approved:
- Adoption of audited standalone and consolidated financial statements for FY26, along with Board and Auditor reports.
- Reappointment of Ankit S Patel (DIN: 02173231), who retired by rotation and was eligible for reappointment.
- Ratification of remuneration for Cost Auditors for FY27.
Voting and scrutiny details
The remote e-voting period ran from September 22, 2026, to September 24, 2026. Members who did not vote remotely were allowed to cast votes electronically during the AGM. Tapan Shah, Practicing Company Secretary, served as the scrutinizer to ensure a fair and transparent voting process under Section 109 of the Companies Act, 2013.
Mayur B Padhya, Chief Financial Officer, responded to shareholder queries on behalf of the Chairman. The company will disclose the consolidated voting results separately to stock exchanges and its website.
Historical Stock Returns for Bodal Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.38% | +9.66% | +140.90% | +263.67% | +209.51% | +83.74% |
How might Ankit S Patel's reappointment influence Bodal Chemicals' strategic direction or governance structure in the coming fiscal year?
What specific growth initiatives or capital expenditures are outlined in the FY26 financial statements that could impact the company's future profitability?
How does the ratified remuneration for Cost Auditors for FY27 compare to industry benchmarks, and what does this imply about the company's cost management priorities?


































